Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Sees Significant Decline in Short Interest

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 70,200 shares, a decline of 31.2% from the January 31st total of 102,100 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Shin Nippon Biomedical Laboratories Price Performance

Shares of SBLOF remained flat at $9.82 during mid-day trading on Tuesday. Shin Nippon Biomedical Laboratories has a one year low of $9.82 and a one year high of $9.82. The business’s fifty day moving average is $9.82 and its 200-day moving average is $13.50.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies.